Patents by Inventor Young-Dae Gong

Young-Dae Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10800788
    Abstract: The present invention relates to a novel 4-(aryl)-N-(3-alkoxyfuro[2,3-b]pyrazin-2-yl)-piperazine-1-carboxamide derivative compound useful in the prevention or treatment of cancer; a preparation method thereof; and a pharmaceutical composition comprising the same. The novel 4-(aryl)-N-(3-alkoxyfuro[2,3-b]pyrazin-2-yl)-piperazine-1-carboxamide derivative compound of the present invention can effectively inhibit the growth of proliferating cells, and thus can be useful in the prevention or treatment of cancer.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: October 13, 2020
    Assignee: LSK NRDO CO., LTD.
    Inventors: Young-Dae Gong, Soo-Youl Kim, Eun Sil Lee, Tae-Sung Koo, Nam-Sook Kang, Na Yeon Kim
  • Publication number: 20190337959
    Abstract: The present invention relates to a novel 4-(aryl)-N-(3-alkoxyfuro[2,3-b]pyrazin-2-yl)-piperazine-1-carboxamide derivative compound useful in the prevention or treatment of cancer; a preparation method thereof; and a pharmaceutical composition comprising the same. The novel 4-(aryl)-N-(3-alkoxyfuro[2,3-b]pyrazin-2-yl)-piperazine-1-carboxamide derivative compound of the present invention can effectively inhibit the growth of proliferating cells, and thus can be useful in the prevention or treatment of cancer.
    Type: Application
    Filed: June 9, 2017
    Publication date: November 7, 2019
    Inventors: Young-Dae Gong, Soo-Youl Kim, Eun Sil Lee, Tae-Sung Koo, Nam-Sook Kang, Na Yeon
  • Patent number: 10059721
    Abstract: The present invention relates to a novel 4-(aryl)-N-(2-alkoxythieno[3,2-b]pyrazin-3-yl)-piperazin-1-carboxamide derivative compound useful in the prevention or treatment of cancer; a preparation method thereof; and a pharmaceutical composition comprising the same. The novel 4-(aryl)-N-(2-alkoxythieno[3,2-b]pyrazin-3-yl)-piperazin-1-carboxamide derivative compound of the present invention can effectively inhibit the growth of proliferating cells, and thus can be useful in the prevention or treatment of cancer.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: August 28, 2018
    Assignee: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Young Dae Gong, Se Hun Kwak, Eun Sil Lee
  • Publication number: 20170320890
    Abstract: The present invention relates to a novel 4-(aryl)-N-(2-alkoxythieno[3,2-b]pyrazin-3 -y)-piperazin-1-carboxamide derivative compound useful in the prevention or treatment of cancer; a preparation method thereof; and a pharmaceutical composition comprising the same. The novel 4-(aryl)-N(2-alkoxythieno[3,2-b]pyrazin-3-yl)-piperazin-1-carboxamide derivative compound of the present invention can effectively inhibit the growth of proliferating cells, and thus can be useful in the prevention or treatment of cancer.
    Type: Application
    Filed: December 3, 2015
    Publication date: November 9, 2017
    Inventors: Young Dae Gong, Se Hun Kwak, Eun Sil Lee
  • Patent number: 8598173
    Abstract: The present invention relates to novel quioxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives of formula (1): and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quioxalin-piperazine compounds are also included.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: December 3, 2013
    Assignees: Korea Research Institute of Chemical Technology, Rexahn Pharmaceuticals, Inc.
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Y. Kong, Gun-Do Kim, Chang Ho Ahn, Young Bok Lee
  • Publication number: 20130164813
    Abstract: The present invention relates to a method for inhibiting transglutaminase 2 activity using 2-alkyloxy-3-phenylethynyl-4a,5-dihydropyrido[2,3-b]pyrazine derivatives.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 27, 2013
    Applicant: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Young Dae Gong, Soo Youl Kim
  • Patent number: 8314100
    Abstract: The present invention related to a novel urea derivative for formula (I): which is useful as an anti-cancer agent, its pharmaceutically acceptable acid addition salt or stereoisomer, and to a process for preparing the urea derivative and an anti-cancer composition comprising the same as an active ingredient.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: November 20, 2012
    Assignees: Rexahn Pharmaceuticals, Inc., Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Yang Kong, Gun-Do Kim, Chang-Ho Ahn, Young Bok Lee
  • Patent number: 8048912
    Abstract: The present invention relates to a novel benzopyran derivative having goodantagonistic activity on TGF-? receptor which can be effectively used as a prophylactic and therapeutic agent for liver disease as well as several fibroplasiadiseases such as hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, dermatosclerosis, glomerular fibrosis and the like; and a pharmaceutical use thereof.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: November 1, 2011
    Assignees: SK Chemicals Co., Ltd., Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Jin-Soo Seo, Moon-Kook Jeon, Wie-Jong Kwak, Yong-Baik Cho, Nam Kyu Lee, Eun Ju Lee, Jung Bum Lee, Jun Won Lee, Sukho Lee, Mi-Sook Dong, Jeong-Ran Kim
  • Patent number: 7915405
    Abstract: Disclosed herein are 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives, a preparation method thereof, and a therapeutic agent for treating inflammatory diseases induced by SPC, which contains the derivative as an active ingredient. The anti-inflammatory effect of the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives was analyzed through a test employing human dermal cells and an animal test using mice and, as a result, it was found that the derivatives showed excellent inhibitory activity on SPC receptor compared to thiazole derivatives known in the prior art. Thus, the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives or pharmaceutically acceptable salts thereof are useful as active ingredients in therapeutic agents for treating inflammatory diseases, such as inflammation, pruritus and skin infection, which appear in atopic dermatitis and other diseases induced by SPC activity. wherein R1, R2, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: March 29, 2011
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Taeho Lee, Moon-Kook Jeon, Heeyeong Cho, Jae Yang Kong, Gildon Choi, Dae Young Jeong, Soon-Hee Hwang
  • Publication number: 20100145043
    Abstract: Disclosed herein are 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives, a preparation method thereof, and a therapeutic agent for treating inflammatory diseases induced by SPC, which contains the derivative as an active ingredient. The anti-inflammatory effect of the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives was analyzed through a test employing human dermal cells and an animal test using mice and, as a result, it was found that the derivatives showed excellent inhibitory activity on SPC receptor compared to thiazole derivatives known in the prior art. Thus, the 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives or pharmaceutically acceptable salts thereof are useful as active ingredients in therapeutic agents for treating inflammatory diseases, such as inflammation, pruritus and skin infection, which appear in atopic dermatitis and other diseases induced by SPC activity. wherein R1, R2, R3 and R4 are as defined in the specification.
    Type: Application
    Filed: September 30, 2009
    Publication date: June 10, 2010
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Young-Dae Gong, Taeho Lee, Moon-Kook Jeon, Heeyeong Cho, Jae Yang Kong, Gildon Choi, Dae Young Jeong, Soon-Hee Hwang
  • Publication number: 20090118302
    Abstract: The present invention relates to a novel benzopyran derivative having goodantagonistic activity on TGF-? receptor which can be effectively used as a prophylactic and therapeutic agent for liver disease as well as several fibroplasiadiseases such as hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, dermatosclerosis, glomerular fibrosis and the like; and a pharmaceutical use thereof.
    Type: Application
    Filed: June 15, 2005
    Publication date: May 7, 2009
    Inventors: Young-Dae Gong, Jin-Soo Seo, Moon-Kook Jeon, Wei-Jong Kwak, Yong-Baik Cho, Nam Kyu Lee, Eun Ju Lee, Jung Bum Lee, Jun Won Lee, Sukho Lee, Mi-Sook Dong, Jeong-Ran Kim
  • Publication number: 20080318963
    Abstract: The present invention relates to novel quinoxaline-piperazine compounds, 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives and their pharmaceutically acceptable salts, a process for their preparation thereof, and compositions containing such compounds. Therapeutic methods for the treatment of hyperproliferative disorders, including cancers, by administering quinoxalin-piperazine compounds are also included.
    Type: Application
    Filed: October 18, 2005
    Publication date: December 25, 2008
    Applicants: REXAHN PHARMACEUTICALS, INC., KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Young-Dae Gong, Moon-Kook Jeon, Dong-Su Kim, Jae Yang Kong, Gun-Do Kim, Chang-Ho Ahn, Young Bok Lee
  • Patent number: 7371874
    Abstract: The present invention relates to a noble 6-alkylamino-2-methyl-2?-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative, a method for preparing the same with high efficiency using a parallel synthetic method, one of combinatorial chemical synthetic techniques, and a use of the novel compound showing a high inhibitory effect to 5-lipoxygenase (5-LO) activity for preventing and treating leukotriene (LTA4, B4, C4, D4) activation-related diseases such as inflammatory diseases, rheumatoid arthritis, colitis, asthma and psoriasis.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: May 13, 2008
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Hyae-Gyeong Cheon, Moon-Kook Jeon, Cho Young Sik, Jong Yeon Hwang, Choi Hyung Sub, Jeon Hyun Suk, Soon-Hee Hwang, Song Jin Sook, Kim Chi Hyun, Sung-eun Yoo
  • Patent number: 7368575
    Abstract: When a multi-step process reaction is carried out in a solution, it generally requires several treatments and purification procedures to go through with after the reaction, however, the inventive method for preparing 2,2?-disubstituted-3,4-dihydro-7,8-disubstituted-6-amino benzopyran derivative using a solid-phased synthetic method simplifies the treatment and purification procedures after the reaction, which makes possible to efficiently construct numerous drug-like libraries.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: May 6, 2008
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Hyae-Gyeong Cheon, Young-Sik Cho, Jin-Soo Seo, Jong-Yeon Hwang, Ji-Yeon Park, Sung-Eun Yoo
  • Publication number: 20070049621
    Abstract: The present invention relates to a noble 6-alkylamino-2-methyl-2?-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative, a method for preparing the same with high efficiency using a parallel synthetic method, one of combinatorial chemical synthetic techniques, and a use of the novel compound showing a high inhibitory effect to 5-lipoxygenase (5-LO) activity for preventing and treating leukotriene (LTA4, B4, C4, D4) activation-related diseases such as inflammatory diseases, rheumatoid arthritis, colitis, asthma and psoriasis.
    Type: Application
    Filed: July 21, 2006
    Publication date: March 1, 2007
    Inventors: Young-Dae Gong, Hyae-Gyeong Cheon, Moon-Kook Jeon, Cho Sik, Jong Hwang, Choi Sub, Jeon Suk, Soon-Hee Hwang, Song Sook, Kim Hyun, Sung-eun Yoo
  • Publication number: 20050203145
    Abstract: When a multi-step process reaction is carried out in a solution, it generally requires several treatments and purification procedures to go through with after the reaction, however, the inventive method for preparing 2,2?-disubstituted-3,4-dihydro-7,8-disubstituted-6-amino benzopyran derivative using a solid-phased synthetic method simplifies the treatment and purification procedures after the reaction, which makes possible to efficiently construct numerous drug-like libraries.
    Type: Application
    Filed: October 20, 2004
    Publication date: September 15, 2005
    Inventors: Young-Dae Gong, Hyae-Gyeong Cheon, Young-Sik Cho, Jin-Soo Seo, Jong-Yeon Hwang, Ji-Yeon Park, Sung-eun Yoo
  • Patent number: 6908942
    Abstract: The present invention provides (i) 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives; (ii) a process for synthesizing benzopyran derivatives with high efficiency by parallel synthesis on a solid-phase as one of combinatorial chemical synthesis technologies; and (iii) a use of the benzopyran derivatives for preventing and treating diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: June 21, 2005
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Young-Dae Gong, Jin-Soo Seo, Jong Yeon Hwang, Sung-eun Yoo
  • Publication number: 20040097580
    Abstract: The present invention provides (i) novel 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives; (ii) a process for synthesizing novel benzopyran derivatives with high efficiency by parallel synthesis on a solid-phase as one of combinatorial chemical synthesis technologies; and (iii) a use of the novel benzopyran derivatives for preventing and treating diseases or disorders induced by promotion of lipid peroxidation or accumulations of oxidized products.
    Type: Application
    Filed: June 16, 2003
    Publication date: May 20, 2004
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Young-Dae Gong, Jin-Soo Seo, Jong Yeon Hwang, Sung-Eun Yoo
  • Patent number: 6482898
    Abstract: The present invention relates to novel halogenated Wang resins for combinational chemical synthesis, more specifically to halogenated Wang resins expressed by formula (1) useful for the effective tracing of combinational chemical synthetic process on solid supports using X-ray photoelectron spectroscopy (XPS) element analysis method; in formula (1), P represents polystyrene-divinylbenzene; X and Y represent hydrogen atom or halogen atom, which may be identical or different, their total number being 1-4; and at least one of them is halogen atom.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: November 19, 2002
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Sung Eun Yoo, Young Dae Gong, Jin Soo Seo